- Home
- SBET vs DRMA Comparison
SBET vs DRMA Comparison
Compare SBET & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- DRMA
- Stock Information
- Founded
- SBET 1995
- DRMA 2014
- Country
- SBET United States
- DRMA United States
- Employees
- SBET N/A
- DRMA N/A
- Industry
- SBET Computer Software: Prepackaged Software
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- SBET Technology
- DRMA Health Care
- Exchange
- SBET Nasdaq
- DRMA Nasdaq
- Market Cap
- SBET 2.4M
- DRMA 2.2M
- IPO Year
- SBET 1997
- DRMA 2021
- Fundamental
- Price
- SBET $0.75
- DRMA $1.06
- Analyst Decision
- SBET
- DRMA Strong Buy
- Analyst Count
- SBET 0
- DRMA 1
- Target Price
- SBET N/A
- DRMA $6.00
- AVG Volume (30 Days)
- SBET 1.6M
- DRMA 588.9K
- Earning Date
- SBET 11-15-2024
- DRMA 11-13-2024
- Dividend Yield
- SBET N/A
- DRMA N/A
- EPS Growth
- SBET N/A
- DRMA N/A
- EPS
- SBET 1.81
- DRMA N/A
- Revenue
- SBET $3,866,015.00
- DRMA N/A
- Revenue This Year
- SBET N/A
- DRMA N/A
- Revenue Next Year
- SBET N/A
- DRMA N/A
- P/E Ratio
- SBET $0.50
- DRMA N/A
- Revenue Growth
- SBET 56.18
- DRMA N/A
- 52 Week Low
- SBET $0.41
- DRMA $1.03
- 52 Week High
- SBET $2.18
- DRMA $13.35
- Technical
- Relative Strength Index (RSI)
- SBET 52.52
- DRMA 41.39
- Support Level
- SBET $0.71
- DRMA $1.03
- Resistance Level
- SBET $0.85
- DRMA $1.43
- Average True Range (ATR)
- SBET 0.15
- DRMA 0.14
- MACD
- SBET 0.01
- DRMA -0.01
- Stochastic Oscillator
- SBET 47.89
- DRMA 11.90
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the Company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The Company has two operating segments: Affiliate Marketing Services-United States and Affiliate Marketing Services-International. The company generates the majority of the revenue earned from the Affiliate Marketing Services-International segment.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.